作者: Robert J. Cherney
DOI:
关键词:
摘要: The present application describes modulators of MCP-1 formula (I): or pharmaceutically acceptable salt forms thereof, useful for the treatment rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.